<DOC>
	<DOC>NCT00165750</DOC>
	<brief_summary>This study investigate the relationship between regional brain volume measured by MRI and donepezil treatment response in patients with Alzheimer's Disease.</brief_summary>
	<brief_title>Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Inclusion criteria: 1. Over 60 years old. 2. Probable or possible Alzheimer's Disease according to the DSMIV and NINCDSADRDA. 3. MMSE score of 10~24, CDR of 1~2. 4. Patients didn't take acetylcholinesterase inhibitors 4 weeks before screening. 5. Permitted drugs: antipsychiatric drug for BPSD, antidepression drug, tranquilizer, treatment drug for physical disease for example hypertension. Exclusion criteria: 1. Uncontrolled by donepezil because of adverse events. 2. No longer continuing treatment of donepezil for refuse, drugdrug interaction etc. 3. If they have taken concomitant medication which were not allowed.</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>